Post-translational modifications regulate signalling by Ror1

Investor logo
Investor logo
Investor logo
Investor logo

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Science. Official publication website can be found on muni.cz.
Authors

KAUCKÁ Markéta KREJČÍ Pavel PLEVOVÁ Karla PAVLOVÁ Šárka PROCHÁZKOVÁ Jiřina JANOVSKÁ Pavlína VALNOHOVÁ Jana KOZUBÍK Alois POSPÍŠILOVÁ Šárka BRYJA Vítězslav

Year of publication 2011
Type Article in Periodical
Magazine / Source Acta Physiologica
MU Faculty or unit

Faculty of Science

Citation
Doi http://dx.doi.org/10.1111/j.1748-1716.2011.02306.x
Field Genetics and molecular biology
Keywords Ror1; posttranslational modifications; glycosylation; chronic lymphocytic leukemia
Description Ror1 (receptor tyrosine kinase-like orphan receptor)is highly upregulated in B cells of patients with chronic lymphocytic leukaemia (CLL). Ror1 acts as the Wnt receptor in the non-canonical Wnt pathway. We demonstrate that Ror1 is extensively modified by N-linked glycosylation. Glycosylation produces several variants of Ror1 with electrophoretic migration of approx. 100, 115 and 130 kDa. Inhibition of glycosylation interferes with cell surface localization of the 130-kDa variant of Ror1 and prevents Ror1-induced formation of filopodia. Moreover, we show that 130-kDa Ror1 is mono-ubiquitinated. Furthermore, individual CLL patients show striking differences in the electrophoretic migration of Ror1, which correspond to the level of glycosylation. Our data show that Ror1 undergoes complex post-translational modifications by glycosylation and mono-ubiquitination. These modifications regulate Ror1 localization and signalling, and are highly variable among individual CLL patients. These may suggest that Ror1 signals only in a subset of CLL patients despite Ror1 levels are ubiquitously high in all CLL patients.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info